
|Articles|February 19, 2016
Therapeutic Innovation & Regulatory Science: An Increasingly Global Approach
Author(s)DIA
Advertisement
After ten years of successive minority and/or majority Conservative leadership, Canada is now led by Prime Minister Justin Trudeau’s Liberal majority. A key component of the Liberal platform is the creation of a Chief Science Officer position to ensure that “scientific analyses are considered when the government makes decisions”; this renewed focus on evidence-based policy may be helpful to science-based industries across a number of sectors.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Releases 2025 Financial Report and 2026 Sales and Operations Profit Outlook
2
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
3
Novartis’ Q4 Recap Shows Signs of Looming Patent Cliff
4
FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo
5



